Binance Labs, the venture capital arm of the Binance cryptocurrency exchange, has invested in decentralized science (DeSci) for the first time. The company has invested in the BIO Protocol accelerator, which supports a network of decentralized autonomous organizations in the field of biotechnology (BioDAO). They create communities to finance, develop and co-own new medicines and therapeutics.
Currently, the BIO Protocol includes eight BioDAO, whose market capitalization reached $200 million in November 2023. One of the accelerator's key projects is the longevity—oriented VitaDAO. It was founded in 2021, and in February 2023 received funding from the pharmaceutical company Pfizer (NYSE:PFE) in the amount of $4.1 million. 
I think this represents a significant step forward in the DeSci sector by combining biotechnology and DeFi.